Trials / Recruiting
RecruitingNCT05148052
Effect of Upper Extremity Rehabilitation Using Immersive Virtual Reality in Chronic Stroke Patients.
Effect of Upper Extremity Rehabilitation Using Fully-immersive Virtual Reality for Motor Recovery in Chronic Stroke Patients: A Prospective, Multicenter, Single-blind, Explorative, Randomized Crossover Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The study aimed to investigate the effect of exergames using virtual reality with head mounted device on motor recovery of upper extremities in chronic stroke patients.
Detailed description
This is a crossover study for comparing conventional occupational therapy and exercise with game format using virtual reality (virtual reality exergame). The virtual reality exergame is designed to maximize the movement of upper extremities, primary to the shoulder and elbow. Fifteen chronic stroke patient will receive conventional occupational treatment and virtual reality exergame in random order with a two-week-washout period. Outcome measures will be evaluated within two days before and after each treatment, conventional treatment and virtual reality exergame. \*Due to recruitment challenges, the anticipated enrollment has been revised from 36 to 15.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Virtual reality exergames | Twelve sessions of virtual reality exergames involving upper extremities will be conducted. Each session is 30 minutes and will be held 3 times a week. The washout period between the two types of interventions is 2 weeks. |
| BEHAVIORAL | Conventional occupational therapy | Conventional occupational therapy involving upper extremities will be conducted. Each session is 30 minutes and will be held 3 times a week. The washout period between the two types of interventions is 2 weeks. |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2025-08-31
- Completion
- 2025-10-31
- First posted
- 2021-12-08
- Last updated
- 2025-06-03
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05148052. Inclusion in this directory is not an endorsement.